[Atrial fibrillation--treatment].
Jung
J
J
Medizinische Klinik und Poliklinik, Innere Medizin III (Kardiologie/Angiologie), Universitätskliniken des Saarlandes, Homburg/Saar. jung@med-in.uni-saarland.de
Böhm
M
M
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy; D018450:Disease Progression; D004554:Electric Countershock; D022062:Electrophysiologic Techniques, Cardiac / Q000379:methods; D006801:Humans; D012307:Risk Factors; D055502:Secondary Prevention; D013923:Thromboembolism / Q000517:prevention & control; D013997:Time Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D014812:Vitamin K